EU OKs Abbott's $25B Acquisition Of St. Jude With Caveats
By Eric Kroh ( November 23, 2016, 4:09 PM EST) -- The European Commission said Wednesday it had given the green light to Abbott Laboratories' $25 billion cash-and-stock acquisition of device maker St. Jude Medical so long as Abbott divests two devices used in cardiovascular treatments....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.